Article info
PDFCorrespondence
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’
- Correspondence to Professor Gianfranco Ferraccioli, Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Lazio, Italy; gianfranco.ferraccioli{at}unicatt.it
Citation
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’
Publication history
- Received October 14, 2020
- Revised October 17, 2020
- Accepted October 17, 2020
- First published November 3, 2020.
Online issue publication
March 31, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage